1. Background {#sec198959}
=============

Biological dosimetry involves biological and biophysical methods to estimate the level of radiation exposure of an accident victim in the absence of physical dosimetry or after large-scale radiological events like the radiation accident in Chernobyl ([@A32013R1], [@A32013R2]). Progress in biological dosimetry via rapid dose assessment is essential to increase survival through medical intervention ([@A32013R3]-[@A32013R5]). The effect of partial body exposure, dose rate, and radiation energy on radiation biological dosimetry has not been studied in the context of radiological or nuclear accidents. Thus, it is of great importance to design studies for the prediction of the absorbed dose in exposed people ([@A32013R6], [@A32013R7]).

Cytogenetic techniques, such as dicentric assay, are time-consuming and cannot be used on the scale that would be necessary in a mass casualty situation ([@A32013R7]); however, gene expression biodosimetry is not a laborious approach. The change in the quantity of RNA transcripts in cells exposed to ionizing radiation suggests that gene expression analysis may enable quantitative dose assessment ([@A32013R8], [@A32013R9]). Up to now, many studies have been conducted to develop a gene expression profiling strategy, but there have been few studies on different energies of ionization radiation ([@A32013R10], [@A32013R11]).

Ionization radiations, such as megavoltage X-ray and neutron radiation, interact with DNA and generate several double-strand breaks (DSBs), cause mitotic death, and change the copy number of mRNA in some genes ([@A32013R12]). DSBs are considered to represent important radiation-induced DNA damage that can result in cell death. DNA damage is critically affected by radiation type and energy ([@A32013R13]).

It is clear that accurate dose estimation can be achieved via the analysis of the genes involved in different pathways, such as cell cycle regulation, DNA repair, and apoptosis ([@A32013R14], [@A32013R15]). Suitable genes show a linear dose-response relationship between the RNA transcription level and the absorbed dose. Microarray is used to find these genes, and the results are verified by real-time polymerase chain reaction (PCR) ([@A32013R4], [@A32013R8], [@A32013R16], [@A32013R17]). The *FDXR* gene is a suitable gene in biological dosimetry with a linear dose response, while *RAD51* is the most important gene for DNA repair in the homologous recombination (HR) mechanism.

2. Objectives {#sec198960}
=============

In this study, the response of the *FDXR* and *RAD51* genes to different doses (0, 0.2, 0.5, 2, and 4 Gy) with beam energies of 6 and 18 MV was recorded to draw the dose-response curve in human peripheral blood.

3. Methods {#sec198968}
==========

3.1. Blood Collection and Ethics {#sec198961}
--------------------------------

In this in vitro experimental study, from 36 students in the medical physics and virology departments, 7 healthy non-smoking male voluntary blood donors of Khuzestan ethnicity who had no history of exposure to ionization radiation were selected using simple randomized sampling. Sixty-three peripheral blood samples were collected from the healthy donors (aged 30 - 35 years). An informed consent form was signed by all participants from Khuzestan Province of Iran. The samples were transferred into K3 EDTA-coated tubes (FL, Italy). This work was approved by the medical ethics committee of Ahvaz Jundishapur University of Medical Sciences (ethical code no. U-92133), Iran. The study was conducted in the virology department at this university from 2013 to 2014.

3.2. Irradiation Conditions and Cell Culture {#sec198962}
--------------------------------------------

All samples were irradiated in a Linac Varian 2100C/D (Varian, USA) in Golestan hospital in Ahvaz (Ahvaz Jundishapur University of Medical Sciences) with a dose rate of 0.3 Gy/min. Sixty-three samples (7 samples per group) were treated and conditioned for the in vitro calibration curve of total body exposure with 0, 0.2, 0.5, 2, and 4 Gy doses at 6 and 18 MV of energy. Dosimetry conditions of all samples included a source-to-surface distance of 100 cm and a field size of 20 × 20 cm.

3.3. RNA Extraction {#sec198963}
-------------------

RNA was prepared from 500 µL of peripheral blood using a High Pure RNA Isolation Kit (Roche, Korea) following the manufacturer's recommendations (for 500 µL of peripheral blood). The quantification of RNA was performed using a NanoDrop-2000 spectrophotometer (Thermo, USA) by analyzing A260/A280 and A260/A230.

3.4. cDNA Synthesis {#sec198964}
-------------------

Total RNA (0.7 µg) was reverse transcribed to cDNA using a High-Capacity cDNA Archive Kit (Thermo, US) according to the manufacturer's instructions. The quality of cDNA synthesis was evaluated by reverse transcription (RT)-PCR and agarose gel electrophoresis. Samples with a sharp band of expected size in the gel were used for amplification by real-time PCR.

3.5. Homemade Standard Construction and Gel Purification for a Standard Curve {#sec198965}
-----------------------------------------------------------------------------

Standard samples were prepared using PCR amplification of total cDNA from lymphocytes using *FDXR* and *RAD51* primers. The PCR products were loaded onto 2% agarose gels with 50 and 100 bp markers for *RAD51* and *FDXR*, respectively. Then, size bands for *FDXR* (85 bp) and *RAD51* (150 bp) were excised from the agarose gels and purified (Bioneer, Daejoon, South Korea). The final concentration of standards was determined using Nanodrop. Ten serial dilutions were prepared (ranging from 10^2^ to 10^6^ *FDXR* and *RAD51* mRNA copies per µL). The PCR reaction volume was 20 µL, and the range of copy numbers/reactions was 5 to 2 × 10^5^.

The concentrations of gel purification products for *FDXR* and *RAD51* genes were 13 ng/µL and 17 ng/µL, respectively. The molecular weights of each copy number from the *FDXR* gene were 52567.77 (8.729035912 × 10^-11^ ng) and 68003.02 daltons (1.13 × 10^-10^ ng), respectively. The schematic representation of the experiment is shown in Appendix 1 in Supplementary File [Figure 1](#fig36696){ref-type="fig"}.

3.6. Quantitative Real-Time PCR {#sec198966}
-------------------------------

PCR amplification was scored as successful using a step one calibrated real-time PCR machine (Applied Bio Systems). The cycling conditions for the *FDXR* gene were as follows: 50°C for 2 minutes and 95°C for 10 minutes, followed by 40 cycles of 95°C for 20 seconds and 60°C for 1 minute. Primers and probes were purchased from Bioneer Inc. (Daejeon, South Korea). The cycling conditions for *RAD51* gene were as follows: 48°C for 10 minutes and 95°C for 10 minutes, followed by 40 cycles of 95°C for 20 seconds and 60°C for 1 minute. The probes were synthesized using 6-carboxyfluorescein (FAM) at the 5ˊ end and a TAMRA quencher at the 3ˊ end.

All reactions were carried out in duplicate using Takara master mix (Japan) with the primer and probe set for *FDXR* and *RAD51* genes at a concentration of 200 nM and 1 µL of cDNA in a 20 µL reaction volume. The designed primers and probes are shown in [Table 1](#tbl50323){ref-type="table"}. Cycle threshold (Ct) values were converted to transcript quantity using standard curves obtained by serial dilution of PCR-amplified cDNA fragments of the *FDXR* and *RAD51* genes. The internal control gene was 18S. 18S and GAPDH have been identified as the most suitable endogenous control genes for gene expression in biological dosimetry, and the latter was used in this study ([@A32013R18]). Briefly, the changes in quantity of the RNA transcripts were measured in the cells exposed to ionizing radiation by real-time PCR.

3.7. Statistical Analysis {#sec198967}
-------------------------

Curve fitting was carried out to fit the mean experimental values using standard regression analysis programs in Microsoft Excel 2007 (Microsoft Corporation, Redmond, WA, USA), and all the statistical tests were done using the Statistical Package for Social Sciences, version 16.0 (SPSS, Inc., Chicago, IL, USA). The Mann-Whitney non-parametric U test was then applied to present the gene expression levels of the *FDXR* and *RAD51* genes under 6 and 18 MV beam energies.

4. Results {#sec198971}
==========

4.1. Quantitative Real-Time PCR Data {#sec198969}
------------------------------------

Demographic data on healthy donors are listed in [Table 2](#tbl50324){ref-type="table"}. Quantitative real-time PCR was conducted for all samples and plotted as an average response ratio. The results are indicated as copy number/reaction. The PCR product was confirmed by size using electrophoretic separation on 2% agarose gel ([Figure 1](#fig36696){ref-type="fig"}). The linear dynamic range of standard curves included five orders of magnitude (from × 10^2^ to × 10^6^ standard cDNA copy number). For all runs, the PCR efficiency was between 89% and 106% for *FDXR* and *RAD51* genes, R^2^ \> 0.98. The Ct for *FDXR* and *RAD51* genes was started at 18 and 21 cycles for the first concentration of standard samples and was finished at 32 and 34 cycles for the last concentration. Typical data from a real-time PCR run are shown in Appendix 2 in Supplementary File, [Figure 2](#fig36697){ref-type="fig"}.

4.2. In Vitro Dose-Response Curve of Blood Irradiation Under 6 and 18 MV Energy Beams {#sec198970}
-------------------------------------------------------------------------------------

The gene expression levels of *FDXR* and *RAD51* were determined for samples 24 hours after irradiation with 0, 0.2, 0.5, 2, and 4 Gy doses with 6 and 18 MV energy beams. The median and IQR of the sample responses for *FDXR* and *RAD51* at all doses are shown in [Table 3](#tbl50325){ref-type="table"}. The best fits for the dose-response curves of both genes were polynomial equations ([Figures 3](#fig36698){ref-type="fig"} and [4](#fig36699){ref-type="fig"}). The results of regression analysis as polynomial equation were fitted to the dose-response curves of the *FDXR* and *RAD51* genes, and goodness of fit (R2) is presented in [Table 4](#tbl50326){ref-type="table"}. Moreover, the p-values for significant differences are shown for the same doses for 6 and 18 MV beam energies.

In the dose-response curve for 6 MV, significant increases were shown in the copy number of the *FDXR* gene at doses of 2 Gy and 4 Gy doses (P \< 0.001 and P \< 0.008, respectively). The dose estimation curve for 18 MV showed the plateau phase for doses higher than 2 Gy.

For the dose response of the *RAD51* gene, an increasing level of gene expression was shown up to 2 Gy at 6 and 18 MV energies of photon beams. After this dose, the descending part of the dose-response curve was well characterized for both energies. A significant increase in the copy number of *RAD51* was revealed at a dose of 2 Gy (P \< 0.040).

![Typical Gel Electrophoresis Data and an Amplification curve for the *RAD51* Gene\
The specific PCR products were confirmed using a 50 bp molecular weight marker for *RAD51* (lane 1). *RAD51*-specific target products were used as the first to fifth concentrations from serial dilutions of standards (lanes 2 - 7).](ircmj-18-11-32013-g001){#fig36696}

![Real-Time PCR Data\
A, The specific PCR products were confirmed using a 100 bp molecular weight marker (lane 6); five samples with dose of 0.5 Gy at both energies are shown (lanes 1 - 5); B, PCR amplification curve for the *RAD51* gene with five concentrations from tenfold serial dilutions.](ircmj-18-11-32013-i001){#fig36697}

![Comparison of the Expression Levels of the *FDXR* Gene in Human Peripheral Blood Lymphocytes at Doses of 0, 0.2, 0.5, 2, and 4 Gy with 6 and 18 MV Photon Beams by Absolute Quantification](ircmj-18-11-32013-i002){#fig36698}

![Comparison of the Expression levels of the *RAD51* Gene in Human Peripheral Blood Lymphocytes at Doses of 0, 0.2, 0.5, 2, and 4 Gy With 6 and 18 MV Photon Beams by Absolute Quantification\
A non-significant increase in gene expression level was observed at different doses of X-ray (except 2 Gy) with 6 and 18 MV beam energies.](ircmj-18-11-32013-i003){#fig36699}

###### Oligonucleotide Primers and Probes

  Gene                           Accession. No   PCR Primers                       Probe               Amplicon Length, bp
  ------------------------------ --------------- --------------------------------- ------------------- ---------------------
  ***FDXR***                     NM-024417       GTCCGTCTGAGTGGGACTTT (Fwd)        CACCTCTGCTGATCCCG   85
  GAGGAGAGACGCTGGAAGAG (Rev)     GCC                                                                   
  ***RAD51***                    NM-024153       GAGGTGAAGGAAAGGCCATGT (Fwd)       TGGCTGAGAGGTATGG    150
  GGGTCTGGTGGTCTGTGTTGA (Rev)    TCTCTCTGGCA                                                           
  ***18S***                      NR-046237       CCTGCCAAGTATGATGACATCAAGA (Fwd)   TGGTGAAGCAGGCGGC    187
  GTAGCCCAGGATGCCCTTTAGT (Rev)   CGAG                                                                  

###### Demographic Characteristics of the Participants (n = 7)^[a](#fn53301){ref-type="table-fn"},[b](#fn53302){ref-type="table-fn"}^

  Variables                   Value (n = 7)
  --------------------------- ----------------------------
  **Weight, kg**              81.58 ± 3.83
  **Age, y**                  33.02 ± 2.32
  **Ethnicity**               Khuzestan province of Iran
  **Body Mass Index (BMI)**   23.5 ± 1.5
  **Gender**                  Male

^a^Values are expressed as mean ± standard deviation (SD) or No. (%).

^b^The inclusion criteria in this study included healthy donors with no history of exposure to ionization radiation and who were non-smokers; The gene expression level in human peripheral blood was compared before and after irradiation; therefore, there were no confounding factors in this experimental study; The blood samples were collected from students in the Medical Physics and Virology departments at the Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran.

###### Real-Time PCR Data From the Irradiated Samples with a 6 MV Energy Beam: Cycle Thresholds (Cts) for *FDXR* and 18S^[a](#fn53303){ref-type="table-fn"}^

  Gene/Energy         Median (IQR)                                                                                                     
  ------------------- -------------------------- --------------------------- ---------------------------- ---------------------------- ----------------------------
  ***FDXR/6 MV***     581.11 (369.39, 1018.30)   830.65 (610.13, 1190.82)    1203.05 (738.38, 1785.42)    2393.59 (1798.21, 2575.37)   2983.00 (2199.48, 3643.82)
  ***FDXR/18 MV***    581.11 (369.39, 1018.30)   1301.09 (924.40, 1490.32)   1332.34 (1091.79, 2131.46)   3779.12 (3051.40, 5120.74)   5051.26 (4704.83, 5859.17)
  ***RAD51/6 MV***    788.30 (573.98, 929.09)    805.38 (507.65, 1280.51)    1195.34 (778.96, 1300.37)    2092.77 (1535.78, 2705.61)   2006.59 (1325.34, 2634.10)
  ***RAD51/18 MV***   788.30 (573.98, 929.09)    803.95 (641.30, 1221.25)    1761.08 (1311.64, 2465.03)   3412.57 (2979.72, 4530.61)   3035.60 (2409.63, 4177.00)

^a^The median with the interquartile range (IQR) of the copy number of RNA was calculated from the molecular weight of each RNA (Nano grams).

###### Results of the Regression Analysis for the Dose-Response Curve of the *FDXR* and *RAD51* Genes and P Values for Significant Differences Between the 6 and 18 MV Beam Energies ([@A32013R1], [@A32013R2])

  Gene/Energy         Equation                               R^2^     P Value                                                                                                                                
  ------------------- -------------------------------------- -------- -------------------------------------------- -------------------------------------------- -------------------------------------------- --------------------------------------------
  ***FDXR/6 MV***     y = -51.198 x^2^ + 773.2 x + 743.75    0.9987   0.2 70^[a](#fn53304){ref-type="table-fn"}^   0.51 3^[a](#fn53304){ref-type="table-fn"}^   0.001^[b](#fn53305){ref-type="table-fn"}^    0.008^[b](#fn53305){ref-type="table-fn"}^
  ***FDXR/18 MV***    y = -243.23 x^2^ + 2003.1 x + 897.15   0.9952                                                                                                                                          
  ***RAD51/6 MV***    y = -210.47 x^2^ + 1215.9 x + 529.91   0.9996   827^[a](#fn53304){ref-type="table-fn"}^      0.2 75^[a](#fn53304){ref-type="table-fn"}^   0.04 0^[b](#fn53305){ref-type="table-fn"}^   0.12 7^[b](#fn53305){ref-type="table-fn"}^
  ***RAD51/18 MV***   y = -307.62 x^2^ + 1832.4 x + 847.15   0.9706                                                                                                                                          

^a^Non-significant differences between the copy numbers of genes at the same doses at 6 and 18 MV photon beam energies.

^b^Significant differences between the copy number of genes at the same doses at 6 and 18 MV photon beam energies (P \< 0.05).

5. Discussion {#sec198973}
=============

In this study, peripheral blood samples were collected from seven healthy donors. Human peripheral blood was then exposed to different doses in 6 and 18 MV beam energies in Linac. After RNA extraction and cDNA synthesis, the expression levels of *FDXR* and *RAD51* were determined at 24 hours post-irradiation. We used the PCR amplification product of total cDNA from lymphocytes using *RAD51* and *FDXR* primers as a standard for absolute quantification in gene expression biological dosimetry. This has the advantages of being a comparatively simple, rapid method. In this study, for the first time, absolute quantification was performed in gene expression biological dosimetry using a gel-purified RT-PCR product as the standard sample. The PCR product was confirmed by size using the gel electrophoresis method. In previous studies, the expression level of *FDXR* was reported in human lymphocytes in radiation response using relative quantification or absolute quantification real-time PCR ([@A32013R9], [@A32013R12], [@A32013R19]-[@A32013R21]).

These genes may be considered as biomarkers of ionization radiation because of increasing expression levels with an increase in dose ([@A32013R22]). *FDXR* is a proper gene for biological dosimetry, so we selected it as a radiation biomarker to compare the results of our quantitative study with previous studies ([@A32013R19]). *RAD51* was also selected because of its important role in the DNA repair mechanism. DNA repair is a biological pathway affected by ionization radiation. In previous studies, the expression level of *RAD51* was reported in human lymphocytes in response to radiation ([@A32013R15], [@A32013R23], [@A32013R24]); however, there has been no in vivo biological dosimetry study for the *RAD51* gene at different radiation doses using real-time PCR.

The best fits for the dose-response curves of the *FDXR* gene included linear and polynomial equations for 6 and 18 MV beam energies. The polynomial equation was the best fit for the *RAD51* dose-response curve. The best fit equation and goodness of fit (R^2^) for both beam energies are given in [Table 4](#tbl50326){ref-type="table"}. In conventional radiotherapy, patients are routinely treated with 6 and 18 MV beam energies, as used in this study. However, there has been no in vivo biological dosimetry study on gene expression with different radiation energies using real-time PCR. The difference in copy number of the *FDXR* and *RAD51* genes under 6 and 18 MV beam energies is related to two components, namely the effect of higher energy (18 MV versus 6 MV) and neutron contamination (photo neutron) at 18 MV. Rapid neutron contamination is caused by X-ray beams over 10 MV ([@A32013R25], [@A32013R26]). [Figures 3](#fig36698){ref-type="fig"} and [4](#fig36699){ref-type="fig"} show that the DNA damage in cells was increased with increasing dose in low and intermediate doses (0.2, 0.5, and 2 Gy). Consequently, the copy number of both genes increased with increasing DNA damage.

The saturation part of the dose-response curve ([Figures 3](#fig36698){ref-type="fig"} and [4](#fig36699){ref-type="fig"}) was predictable in the presence of sub-lethal damage repair and cellular repopulation. The complicated issue was the plateau of the curve, which was not shown in the dose-response curve of the *FDXR* gene at 6 MV of photon energy. However, the plateau was observed in the dose--response curve at 18 MV of energy after a 2 Gy dose. Manning et al. investigated the *FDXR* dose-response curve under different irradiation conditions. They reported a plateau in the dose-response curve of the *FDXR* gene. This was related to the in vitro conditions of cell culture or cell death in high-dose irradiation in Manning et al.'s study, while the plateau was observed after a 2 Gy dose at 18 MV of energy in our study. We suggest that cell death is the most important reason for the plateau in the dose-response curve.

In the dose-response curve of the high-dose group at 6 MV of photon energy, the expression level of the *FDXR* gene was increased with an increasing photon dose. A possible explanation for this is that the megavoltage photons create noticeable sub-lethal DNA damage, and the expression level of the *FDXR* gene is increased in response to this damage. Sub-lethal DNA damage is then repaired by the DNA repair mechanisms, and cell survival increases.

Photo-neutrons created lethal DNA damage at high doses of the dose-response curve and 18 MV of energy. After radiation, lethal damage was induced and cell death mechanisms (apoptosis and mitotic death) led to a decrease in the measured level of mRNA transcripts. This plateau may be related to a high expression level of the *FDXR* gene at high doses. In contrast, there was significant cell death within 24 hours after irradiation. The photo-neutron dose equivalent was reported to be a 1 - 3 mSv/Gy dose on the skin with an 18 MV photon beam (mSv per unit photon Gy delivered to isocenter) ([@A32013R27]). Thus, it is understandable why the Mann-Whitney test showed significant differences (P \< 0.001 and P \> 0.008, respectively) between 6 and 18 MV for 2 Gy and 4 Gy doses in the *FDXR* gene ([Table 4](#tbl50326){ref-type="table"}). However, we think that analysis of *FDXR* expression may be a good biomarker for discrimination of radiation at different energy levels with intermediate and high doses.

The dose-response curve of the *RAD51* gene only showed a significant difference (P \< 0.040) at 2 Gy with 6 and 18 MV beams. The dose-response curve of the *RAD51* gene at 6 and 18 MV of energy showed increasing expression levels up to 2 Gy and then a constant expression level that was similar to the dose-response curve of the FDXR gene (as shown in [Figure 3](#fig36698){ref-type="fig"}); however, differences and more complications were observed. The great variation in the number of *RAD51* copies compared to *FDXR* and the lower effectiveness of radiation energy on the expression of the *RAD51* gene compared to the *FDXR* gene may be related to the DNA repair mechanisms.

Peripheral blood lymphocytes are usually in the resting G0 phase. Homologous recombination (HR) is frequently initiated when a DSB occurs soon after DNA has been replicated, namely in the S or G2 phases, and non-homologous end-joining (NHEJ) is the dominant mechanism of DNA repair after DSBs in G1 and G0. The HR and NHEJ mechanisms are differentially regulated depending on two factors, namely the nature of the DSB and the cell cycle phase in mammalian cells ([@A32013R28], [@A32013R29]). The variation in the copy number of *RAD51* and the less prominent effect on radiation quality can be related to this mechanism. It is possible to simultaneously measure the expression level of principal genes in the NHEJ mechanism in association with the *RAD51* gene for use in biological dosimetry.

Briefly, the increasing expression level of *FDXR* gene in the dose response compared to *RAD51* was consistent with the hypothesis that the *FDXR* gene is superior to *RAD51* for quantitative dose and energy assessment in gene expression biological dosimetry. In future, several genes should be checked in relation to different pathways, including the cell cycle and apoptosis. The low sample size was another weak point of our study. A larger sample size could improve the accuracy of the study. The study of well-known genes, such as CDKN1, GADD45, and so on, in response to different heterogeneous high-energy X-rays is suggested.

5.1. Conclusion {#sec198972}
---------------

In contrast to the *RAD51* gene, *FDXR* is a suitable gene for quantitative dose and energy assessment in biological dosimetry, even in high energy X-rays.

Supplements {#sec199984}
===========

Supplementary material(s) is available \|http://ircmj.com/?page=download&file_id=64909\|.
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